Jump Financial, LLC Beyond Spring Inc. Transaction History

Jump Financial, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$4.02 - $16.84 $205,807 - $862,140	-51,196 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$9.26 - $31.31 $374,066 - $1.26 Million	40,396 Added 374.04%	51,196 $807,000
Q2 2021 Aug 13, 2021	BUY	$9.37 - $12.12 $101,195 - $130,895	10,800 New	10,800 $113,000
Q1 2021 May 17, 2021	SELL	$10.61 - $15.77 $165,516 - $246,012	-15,600 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$10.21 - $17.31 $159,276 - $270,036	15,600 New	15,600 $190,000

5.44M

30.3K

1.8K

Ticker BYSI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,928,900
Market Cap $95.4M
Description
BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.